The VA Breast Cancer Foundation is a 501c3 dedicated to education and advocacy for Virginians affected by breast cancer. EDUCATE. ADVOCATE. ERADICATE.
Virginia
Joined March 2010
- Tweets1.3K
- Following137
- Followers248
- Likes77
Thank you, @RepJenKiggans for meeting with Virginia breast cancer advocates today! We hope we can count on your support for HR549, the Metastatic Breast Cancer Access to Care Act. #nbcconthehill
Thank you, @RepMcClellan for supporting the Department of Defense Breast Cancer Research Program. Can we count on you to support HB549 to waive #Medicare and SSDI waiting periods for people with #metastaticbc? #NBCConTheHill #VBCFconnection
VBCF retweeted
Thank you to @RepBobGood and his staff for meeting with Virginia advocates on #LobbyDay! We look forward to working with you to #StopBreastCancer. #NBCContheHill
Thank you, Congressman Bobby Scott, for co-sponsoring HR549, the Metastatic Breast Cancer Access to Care Act! We are grateful for your continued support of this bill and of the breast cancer community. #NBCConTheHill @NBCCStopBC
Virginia breast cancer survivors, thrivers, and advocates enjoyed meeting with @RepBenCline's staff today. Representative Cline, we hope we can count on your support for HR549, to help women and men with metastatic breast cancer. #NBCConTheHill @NBCCStopBC
VCU Massey researchers may have found a therapeutic target in triple negative breast cancer sciencedaily.com/releases/20…
We heard about the microbiome from Dr. Rutkowski (check out our website blog page for the video), and she just published an article with some colleagues about the microbiome and breast cancer.ascopost.com/news/september-…
FDA informs that more types of breast implants can be connected to increased risk of rare cancers fda.gov/medical-devices/safe…
Enhertu earns FDA approval, which provides potential to re-classify some triple-negative disease as HER2-low and a new treatment option for metastatic disease. pharmacytimes.com/view/fda-a…
The potential game-changer Enhertu could be under FDA review by the end of the year fiercepharma.com/pharma/enhe…
Younger, non-white breast cancer patients more likely to have pain and other symptoms underrecognized by their physicians jamanetwork.com/journals/jam…
Black women more likely to experience delay of 30,60, or 90 days between abnormal screening mammo and biopsy.
jamanetwork.com/journals/jam…
Thank you @RepMcEachin for co-sponsoring HR3183 the Metastatic Breast Cancer Access to Care Act. This critical bill waives the waiting periods for #Medicare and SSDI benefits and ensures that patients #metastaticbc get the care they need as soon as possible. @NBCCStopBC #bcsm
Can the #breastcancer community count on you? @RepDonBeyer @RepBobGood @RobWittman @RepMcEachin @RepBenCline We need YOUR support for HR3183 to waive #Medicare and SSDI waiting periods for people with #metastaticbc. @NBCCStopBC #bcsm
On behalf of VBCF advocates and all Virginians impacted by breast cancer, THANK YOU, @RepWexton, for co-sponsoring the Metastatic Breast Cancer Access to Care Act - helping patients get the care they need as soon as possible.
New wearable tech cleared by FDA, being tested for breast cancer screening. medcitynews.com/2022/05/fda-…
Thank you for the virtual meeting today with breast cancer advocates. @RepWexton, we need your support for HR3183 to waive #Medicare and SSDI waiting periods for people with #metastaticbc. Can the #breastcancer community count on you? @NBCCStopBC #NBCConTheHill #bcsm
Enhertu was granted breakthrough therapy status for non-resectable and metastatic HER2 low breast cancer pharmtech.com/view/enhertu-g…
VBCF advocates are meeting with members of VA's Congressional delegation today to ask them to support HR 3183 - Metastatic Breast Cancer Access to Care Act @NBCCStopBC #bcsm #NBCConTheHill